This inventor holds 1 USPTO granted patent. Top assignees: The Rockefeller University, The State University of New York. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2014
Title: The Innovations of Santosh T Menon
Introduction
Santosh T Menon is a notable inventor based in Edgewater, NJ (US). He has made significant contributions to the field of biochemistry, particularly through his innovative work on protein variants. His research focuses on the therapeutic applications of these proteins, which have the potential to address critical health issues.
Latest Patents
Santosh T Menon holds 1 patent for his invention titled "Nucleobindin I variant protein compositions and methods of use." This invention relates to Nucleobindin-1 (NUCB1) protein variants that are capable of disaggregating amyloid fibrils and inhibiting the formation of fibrils in the presence of physiological concentrations of calcium. The patent encompasses isolated NUCB1 protein variants, nucleic acids encoding these variants, cells comprising the isolated nucleic acids, pharmaceutical compositions, and kits that include the variants. Additionally, it outlines methods for making the variants and their therapeutic uses.
Career Highlights
Throughout his career, Santosh T Menon has worked with prestigious institutions such as The Rockefeller University and The State University of New York. His work has been instrumental in advancing the understanding of protein functions and their applications in medicine.
Collaborations
Some of his notable coworkers include Dan Raleigh and Thomas P Sakmar. Their collaborative efforts have contributed to the success of various research projects and innovations in the field.
Conclusion
Santosh T Menon's contributions to the field of biochemistry through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in therapeutic applications of protein variants.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile